olaparib,bevacizumab
Merck,Astrazeneca
['bevacizumab', 'vance', 'olaparib', 'ovarian', 'merck', 'astrazeneca']
new from #esmo22 maintenance therapy with olaparib and bevacizumab extended survival for certain women with newly diagnosed advanced ovarian cancer. 
The content you need, when you need it.